Home
About Us
Overview
Management Team
Board of Directors
Scientific & Clinical Advisors
Partnerships
The DPX Platform
Overview
Scientific Publications & Posters
Clinical Pipeline
Overview
DPX-Survivac
DPX-RSV
DPX-COVID-19
Clinical Trials
News & Events
Press Releases
Events
Email Alerts
Investors
Overview
Press Releases
Events, Webcasts & Presentations
Financial Info
Stock Data
Filings
Governance
Contact Us
FAQ
Careers
Overview
Life at IMV
Contact
SEC Filings
Investors
Investors
Overview
Press Releases
Events, Webcasts & Presentations
Overview
Presentations
Scientific Publications & Posters
Email Alerts
Financial Info
Financial Results
Tax Info
Proxy Info
Stock Option Plan
Deferred Share Unit Plan
Stock Data
NASDAQ: IMV
TSX: IMV
Analyst Coverage
Filings
SEC Filings
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
FAQ
Filings
SEC Filings
SEDAR
Filing Type:
View All
40-F
40-F/A
40FR12B
40FR12B/A
6-K
CERT
D
EFFECT
F-10
F-10/A
F-X
F-X/A
POS AM
S-8
S-8 POS
SC 13D
SC 13G
SC 13G/A
SUPPL
Year:
View All
2020
2019
2018
Date
Form
Description
PDF
XBRL
Pages
09/16/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
08/26/20
40-F/A
Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4
Documents
EX-99.4
EX-99.5
7
08/26/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
08/12/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
10
08/12/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
EX-99.2
EX-99.3
EX-99.4
51
08/05/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
7
08/04/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
07/30/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
18
07/29/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
07/20/20
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
6
1
2
3
4
5
6
7
8
9
10
…15
Next
Email Alerts
Contacts
RSS News Feed